RecruitingPhase 3NCT05814432
Rare condition
Histoplasmosis
2
studies recruiting now
as of 7 Sept 2026
32
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
10 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 4NCT07695298
A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Histoplasmosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Histoplasmosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Histoplasmosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Amphotericin B (Abelcet)Approved: Itraconazole (Fungitraxx)
Phase 3Ibrexafungerp
Phase 1/2Ranibizumab (Byooviz)
Phase 1/2Aflibercept (Eylea)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).